Richter Stefan E, Roberts Kari E, Preston Ioana R, Hill Nicholas S
Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, Los Angeles, Los Angeles, CA.
Division of Pulmonary, Critical Care, and Sleep Medicine, Tufts Medical Center, Boston, MA.
Chest. 2016 May;149(5):1261-8. doi: 10.1378/chest.15-0819. Epub 2016 Jan 12.
One of the foremost diagnostic challenges in clinical pulmonary hypertension is discriminating between pulmonary arterial hypertension (group 1) and heart failure with preserved ejection fraction (group 2.2). Group 2.2 is defined as a normal left ventricular ejection fraction (> 50%) and a pulmonary arterial wedge pressure (PAWP) > 15 mm Hg. We aimed to determine whether patient history, demographics, and noninvasive measures could predict PAWP before to right heart catheterization.
Data were prospectively collected on 350 consecutive patients at a single tertiary care medical center; of these patients, 151 met criteria for entry into our study (88 in group 1 and 63 in group 2.2). Data included historical features, demographics, and results of a transthoracic echocardiogram. A multivariate regression model was developed to predict PAWP > 15 mm Hg.
Univariate predictors of PAWP > 15 mm Hg included older age, higher BMI and weight, systemic systolic BP and pulse pressure, more features of the metabolic syndrome, presence of hypertension and left atrial enlargement, absence of right ventricular enlargement, and lower glomerular filtration rate and 6-min walk distance. The optimal model for predicting PAWP > 15 mm Hg was composed of age (> 68 years), BMI (> 30 kg/m(2)), absence of right ventricular enlargement, and presence of left atrial enlargement (area under the curve, 0.779).
Clinical characteristics obtained before diagnostic right heart catheterization accurately predict the probability of elevation of PAWP > 15 mm Hg in patients with preserved ejection fraction. These combined clinical characteristics can be used a priori to predict the likelihood of group 2.2 pulmonary hypertension.
临床肺动脉高压最主要的诊断挑战之一是区分肺动脉高压(第1组)和射血分数保留的心力衰竭(第2.2组)。第2.2组定义为左心室射血分数正常(>50%)且肺动脉楔压(PAWP)>15 mmHg。我们旨在确定患者病史、人口统计学特征和非侵入性测量方法能否在右心导管检查前预测PAWP。
在一家三级医疗中心前瞻性收集了350例连续患者的数据;其中151例符合纳入本研究的标准(第1组88例,第2.2组63例)。数据包括病史特征、人口统计学特征和经胸超声心动图结果。建立了多元回归模型来预测PAWP>15 mmHg。
PAWP>15 mmHg的单变量预测因素包括年龄较大、BMI和体重较高、体循环收缩压和脉压、代谢综合征的更多特征、高血压和左心房扩大的存在、右心室扩大的不存在、较低的肾小球滤过率和6分钟步行距离。预测PAWP>15 mmHg的最佳模型由年龄(>68岁)、BMI(>30 kg/m²)、右心室扩大的不存在和左心房扩大的存在组成(曲线下面积,0.779)。
在诊断性右心导管检查前获得的临床特征可准确预测射血分数保留的患者PAWP>15 mmHg升高的概率。这些综合临床特征可用于先验预测第2.2组肺动脉高压的可能性。